Skip to main content
PMC home page
Protein & Cell logoLink to Protein & Cell
. 2010 Feb 7;1(1):59–74. doi: 10.1007/s13238-010-0011-4

Liberation of SARS-CoV main protease from the viral polyprotein: N-terminal autocleavage does not depend on the mature dimerization mode

Shuai Chen 1, Felix Jonas 1, Can Shen 1, Rolf Higenfeld 1,2,✉
PMCID: PMC4875104  PMID: 21203998

Abstract

The main protease (Mpro) plays a vital role in proteolytic processing of the polyproteins in the replicative cycle of SARS coronavirus (SARS-CoV). Dimerization of this enzyme has been shown to be indispensable for transcleavage activity. However, the auto-processing mechanism of Mpro, i.e. its own release from the polyproteins through autocleavage, remains unclear. This study elucidates the relationship between the N-terminal autocleavage activity and the dimerization of “immature” Mpro. Three residues (Arg4, Glu290, and Arg298), which contribute to the active dimer conformation of mature Mpro, are selected for mutational analyses. Surprisingly, all three mutants still perform N-terminal autocleavage, while the dimerization of mature protease and transcleavage activity following auto-processing are completely inhibited by the E290R and R298E mutations and partially so by the R4E mutation. Furthermore, the mature E290R mutant can resume N-terminal autocleavage activity when mixed with the “immature” C145A/E290R double mutant whereas its trans-cleavage activity remains absent. Therefore, the N-terminal auto-processing of Mpro appears to require only two “immature” monomers approaching one another to form an “intermediate” dimer structure and does not strictly depend on the active dimer conformation existing in mature protease. In conclusion, an auto-release model of Mpro from the polyproteins is proposed, which will help understand the auto-processing mechanism and the difference between the autocleavage and trans-cleavage proteolytic activities of SARS-CoV Mpro.

Keywords: SARS-CoV Mpro, N-terminal autocleavage, autocleavage activity, trans-cleavage activity, dimerization

Footnotes

An erratum to this article is available at http://dx.doi.org/10.1007/s13238-010-0041-y.

References

  1. Anand, K., Yang, H., Bartlam, M., Rao, Z., and Hilgenfeld, R. (2005). Coronavirus main proteinase: target for antiviral drug therapy. In Coronaviruses with special emphasis on first insights concerning SARS. A. Schmidt, M.H. Wolf and O. Weber, ed. (Basel, Birkhäuser) pp. 173–199.
  2. Anand K., Ziebuhr J., Wadhwani P., Mesters J.R., Hilgenfeld R. Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs. Science. 2003;300:1763–1767. doi: 10.1126/science.1085658. [DOI] [PubMed] [Google Scholar]
  3. Barrila J., Bacha U., Freire E. Long-range cooperative interactions modulate dimerization in SARS 3CLpro. Biochemistry. 2006;45:14908–14916. doi: 10.1021/bi0616302. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Chen S., Chen L., Tan J., Chen J., Du L., Sun T., Shen J., Chen K., Jiang H., Shen X. Severe acute respiratory syndrome coronavirus 3C-like proteinase N terminus is indispensable for proteolytic activity but not for enzyme dimerization. Biochemical and thermodynamic investigation in conjunction with molecular dynamics simulations. J Biol Chem. 2005;280:164–173. doi: 10.1074/jbc.M408211200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Chen S., Hu T., Zhang J., Chen J., Chen K., Ding J., Jiang H., Shen X. Mutation of Gly-11 on the dimer interface results in the complete crystallographic dimer dissociation of severe acute respiratory syndrome coronavirus 3C-like protease: crystal structure with molecular dynamics simulations. J Biol Chem. 2008;283:554–564. doi: 10.1074/jbc.M705240200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Chen S., Zhang J., Hu T., Chen K., Jiang H., Shen X. Residues on the dimer interface of SARS coronavirus 3C-like protease: dimer stability characterization and enzyme catalytic activity analysis. J Biochem. 2008;143:525–536. doi: 10.1093/jb/mvm246. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Chou C.Y., Chang H.C., Hsu W.C., Lin T.Z., Lin C.H., Chang G.G. Quaternary structure of the severe acute respiratory syndrome (SARS) coronavirus main protease. Biochemistry. 2004;43:14958–14970. doi: 10.1021/bi0490237. [DOI] [PubMed] [Google Scholar]
  8. Drosten C., Preiser W., Gunther S., Schmitz H., Doerr H.W. Severe acute respiratory syndrome: identification of the etiological agent. Trends Mol Med. 2003;9:325–327. doi: 10.1016/S1471-4914(03)00133-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Fan K., Wei P., Feng Q., Chen S., Huang C., Ma L., Lai B., Pei J., Liu Y., Chen J., et al. Biosynthesis, purification, and substrate specificity of severe acute respiratory syndrome coronavirus 3C-like proteinase. J Biol Chem. 2004;279:1637–1642. doi: 10.1074/jbc.M310875200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Graziano V., McGrath W.J., DeGruccio A.M., Dunn J.J., Mangel W.F. Enzymatic activity of the SARS coronavirus main proteinase dimer. FEBS Lett. 2006;580:2577–2583. doi: 10.1016/j.febslet.2006.04.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Graziano V., McGrath W.J., Yang L., Mangel W.F. SARS-CoV main proteinase: The monomer-dimer equilibrium dissociation constant. Biochemistry. 2006;45:14632–14641. doi: 10.1021/bi061746y. [DOI] [PubMed] [Google Scholar]
  12. Groneberg D.A., Hilgenfeld R., Zabel P. Molecular mechanisms of severe acute respiratory syndrome (SARS) Respir Res. 2005;6:8–23. doi: 10.1186/1465-9921-6-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Hsu M.F., Kuo C.J., Chang K.T., Chang H.C., Chou C.C., Ko T.P., Shr H.L., Chang G.G., Wang A.H., Liang P.H. Mechanism of the maturation process of SARS-CoV 3CL protease. J Biol Chem. 2005;280:31257–31266. doi: 10.1074/jbc.M502577200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hsu W.C., Chang H.C., Chou C.Y., Tsai P.J., Lin P.I., Chang G.G. Critical assessment of important regions in the subunit association and catalytic action of the severe acute respiratory syndrome coronavirus main protease. J Biol Chem. 2005;280:22741–22748. doi: 10.1074/jbc.M502556200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hu T., Zhang Y., Li L., Wang K., Chen S., Chen J., Ding J., Jiang H., Shen X. Two adjacent mutations on the dimmer interface of SARS coronavirus 3C-like protease cause different conformational changes in crystal structure. Virology. 2009;388:324–334. doi: 10.1016/j.virol.2009.03.034. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Huang C., Wei P., Fan K., Liu Y., Lai L. 3C-like proteinase from SARS coronavirus catalyzes substrate hydrolysis by a general base mechanism. Biochemistry. 2004;43:4568–4574. doi: 10.1021/bi036022q. [DOI] [PubMed] [Google Scholar]
  17. Jeng M.F., Campbell A.P., Begley T., Holmgren A., Case D.A., Wright P.E., Dyson H.J. High-resolution solution structures of oxidized and reduced Escherichia coli thioredoxin. Structure. 1994;2:853–868. doi: 10.1016/S0969-2126(94)00086-7. [DOI] [PubMed] [Google Scholar]
  18. Knoops K., Kikkert M., van den Worm S.H., Zevenhoven-Dobbe J. C., van der Meer Y., Koster A.J., Mommaas A.M., Snijder E. J. SARS-coronavirus replication is supported by a reticulovesicular network of modified endoplasmic reticulum. PLoS Biol. 2008;6:e226. doi: 10.1371/journal.pbio.0060226. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Lee T.W., Cherney M.M., Huitema C., Liu J., James K.E., Powers J.C., Eltis L.D., James M.N. Crystal structures of the main peptidase from the SARS coronavirus inhibited by a substrate-like aza-peptide epoxide. J Mol Biol. 2005;353:1137–1151. doi: 10.1016/j.jmb.2005.09.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Lin C.W., Tsai C.H., Tsai F.J., Chen P.J., Lai C.C., Wan L., Chiu H. H., Lin K.H. Characterization of trans- and ciscleavage activity of the SARS coronavirus 3CLpro protease: basis for the in vitro screening of anti-SARS drugs. FEBS Lett. 2004;574:131–137. doi: 10.1016/j.febslet.2004.08.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Lin P.Y., Chou C.Y., Chang H.C., Hsu W.C., Chang G.G. Correlation between dissociation and catalysis of SARSCoV main protease. Arch Biochem Biophys. 2008;472:34–42. doi: 10.1016/j.abb.2008.01.023. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Marra M.A., Jones S.J., Astell C.R., Holt R.A., Brooks-Wilson A., Butterfield Y.S., Khattra J., Asano J.K., Barber S.A., Chan S.Y., et al. The genome sequence of the SARS-associated coronavirus. Science. 2003;300:1399–1404. doi: 10.1126/science.1085953. [DOI] [PubMed] [Google Scholar]
  23. Nishida M., Harada S., Noguchi S., Satow Y., Inoue H., Takahashi K. Three-dimensional structure of Escherichia coli glutathione S-transferase complexed with glutathione sulfonate: catalytic roles of Cys10 and His106. J Mol Biol. 1998;281:135–147. doi: 10.1006/jmbi.1998.1927. [DOI] [PubMed] [Google Scholar]
  24. Oostra M., Hagemeijer M.C., van Gent M., Bekker C.P., te Lintelo E.G., Rottier P.J., de Haan C.A. Topology and membrane anchoring of the coronavirus replication complex: not all hydrophobic domains of nsp3 and nsp6 are membrane spanning. J Virol. 2008;82:12392–12405. doi: 10.1128/JVI.01219-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Peiris J.S., Lai S.T., Poon L.L., Guan Y., Yam L.Y., Lim W., Nicholls J., Yee W.K., Yan W.W., Cheung M.T., et al. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet. 2003;361:1319–1325. doi: 10.1016/S0140-6736(03)13077-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Prakash K., Prajapati S., Ahmad A., Jain S.K., Bhakuni V. Unique oligomeric intermediates of bovine liver catalase. Protein Sci. 2002;11:46–57. doi: 10.1110/ps.ps.20102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Shan Y.F., Li S.F., Xu G.J. A novel auto-cleavage assay for studying mutational effects on the active site of severe acute respiratory syndrome coronavirus 3C-like protease. Biochem Biophys Res Commun. 2004;324:579–583. doi: 10.1016/j.bbrc.2004.09.088. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Shi J., Song J. The catalysis of the SARS 3C-like protease is under extensive regulation by its extra domain. Febs J. 2006;273:1035–1045. doi: 10.1111/j.1742-4658.2006.05130.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Shi J., Sivaraman J., Song J. Mechanism for controlling the dimer-monomer switch and coupling dimerization to catalysis of the severe acute respiratory syndrome coronavirus 3C-like protease. J Virol. 2008;82:4620–4629. doi: 10.1128/JVI.02680-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Shi J., Wei Z., Song J. Dissection study on the severe acute respiratory syndrome 3C-like protease reveals the critical role of the extra domain in dimerization of the enzyme: defining the extra domain as a new target for design of highly specific protease inhibitors. J Biol Chem. 2004;279:24765–24773. doi: 10.1074/jbc.M311744200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Snijder E.J., Bredenbeek P.J., Dobbe J.C., Thiel V., Ziebuhr J., Poon L.L., Guan Y., Rozanov M., Spaan W.J., Gorbalenya A.E. Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage. J Mol Biol. 2003;331:991–1004. doi: 10.1016/S0022-2836(03)00865-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Snijder E.J., van der Meer Y., Zevenhoven-Dobbe J., Onderwater J. J., van der Meulen J., Koerten H.K., Mommaas A.M. Ultrastructure and origin of membrane vesicles associated with the severe acute respiratory syndrome coronavirus replication complex. J Virol. 2006;80:5927–5940. doi: 10.1128/JVI.02501-05. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Tan J.Z., Verschueren K.H.G., Anand K., Shen J.H., Yang M.J., Xu Y.C., Rao Z.H., Bigalke J., Heisen B., Mesters J.R., et al. pH-dependent conformational flexibility of the SARS-CoV main proteinase (Mpro) dimer: molecular dynamics simulations and multiple X-ray structure analyses. J Mol Biol. 2005;354:25–40. doi: 10.1016/j.jmb.2005.09.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Thiel V., Ivanov K.A., Putics A., Hertzig T., Schelle B., Bayer S., Weissbrich B., Snijder E.J., Rabenau H., Doerr H.W., et al. Mechanisms and enzymes involved in SARS coronavirus genome expression. J Gen Virol. 2003;84:2305–2315. doi: 10.1099/vir.0.19424-0. [DOI] [PubMed] [Google Scholar]
  35. Verschueren K.H., Pumpor K., Anemuller S., Chen S., Mesters J. R., Hilgenfeld R. A structural view of the inactivation of the SARS coronavirus main proteinase by benzotriazole esters. Chem Biol. 2008;15:597–606. doi: 10.1016/j.chembiol.2008.04.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Wei P., Fan K., Chen H., Ma L., Huang C., Tan L., Xi D., Li C., Liu Y., Cao A., et al. The N-terminal octapeptide acts as a dimerization inhibitor of SARS coronavirus 3C-like proteinase. Biochem Biophys Res Commun. 2006;339:865–872. doi: 10.1016/j.bbrc.2005.11.102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Xue X., Yang H., Shen W., Zhao Q., Li J., Yang K., Chen C., Jin Y., Bartlam M., Rao Z. Production of authentic SARSCoV Mpro with enhanced activity: application as a novel tagcleavage endopeptidase for protein overproduction. J Mol Biol. 2007;366:965–975. doi: 10.1016/j.jmb.2006.11.073. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Xue X., Yu H., Yang H., Xue F., Wu Z., Shen W., Li J., Zhou Z., Ding Y., Zhao Q., et al. Structures of two coronavirus main proteases: implications for substrate binding and antiviral drug design. J Virol. 2008;82:2515–2527. doi: 10.1128/JVI.02114-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Yang H., Yang M., Ding Y., Liu Y., Lou Z., Zhou Z., Sun L., Mo L., Ye S., Pang H., et al. The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor. Proc Natl Acad Sci U S A. 2003;100:13190–13195. doi: 10.1073/pnas.1835675100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Zhong N., Zhang S., Xue F., Kang X., Zou P., Chen J., Liang C., Rao Z., Jin C., Lou Z., et al. C-terminal domain of SARSCoV main protease can form a 3D domain-swapped dimer. Protein Sci. 2009;18:839–844. doi: 10.1002/pro.76. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Zhong N., Zhang S., Zou P., Chen J., Kang X., Li Z., Liang C., Jin C., Xia B. Without its N-finger, the main protease of severe acute respiratory syndrome coronavirus can form a novel dimer through its C-terminal domain. J Virol. 2008;82:4227–4234. doi: 10.1128/JVI.02612-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Ziebuhr J. Molecular biology of severe acute respiratory syndrome coronavirus. Curr Opin Microbiol. 2004;7:412–419. doi: 10.1016/j.mib.2004.06.007. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Protein & Cell are provided here courtesy of Oxford University Press

RESOURCES